Source: BEFREE
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-X-C motif chemokine ligand 2 | 0.513 | 0.885 | 3.6E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2016 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2009 | ||||||||
|
Kruppel like factor 5 | 0.534 | 0.769 | 0.82 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.300 | None | 0.972 | 35 | 2 | 2008 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.300 | None | 0.963 | 26 | 2 | 2004 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.300 | None | 0.963 | 26 | 0 | 2003 | 2019 | ||||||||
|
mucin 5AC, oligomeric mucus/gel-forming | 0.483 | 0.808 | 1.0E-08 |
|
disease | 0.300 | None | 1.000 | 16 | 0 | 2004 | 2020 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.300 | None | 1.000 | 11 | 1 | 2001 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.280 | None | 0.889 | 8 | 0 | 2012 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.250 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.240 | None | 1.000 | 4 | 0 | 2007 | 2017 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.230 | None | 1.000 | 3 | 0 | 2011 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 2009 | 2015 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
DNA damage inducible transcript 3 | 0.467 | 0.846 | 0.59 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2014 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
BCL2 interacting protein 3 | 0.520 | 0.731 | 2.0E-05 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.200 | None | 0.970 | 26 | 6 | 2009 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 1.000 | 23 | 2 | 2001 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.200 | None | 1.000 | 17 | 2 | 2010 | 2019 | ||||||||
|
iron responsive element binding protein 2 | 0.619 | 0.577 | 1.00 |
|
disease | 0.200 | None | 0.905 | 15 | 9 | 2009 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 13 | 3 | 2010 | 2019 |